Thus, a comprehensive assessment of the metabolic effects of melatonin treatment with direct measurements of insulin sensitivity and β‐cell function in patients with type 2 diabetes stratified on rs10830963 genotype is warranted. Here, INS is linked to type 2 diabetes mellitus.